BCL2 and neoplasm: The binding of venetoclax to the BH-3 domain of BCL-2 leads to the displacement of the pro-apoptotic protein BIM from BCL-2, and the subsequent activation of cytochrome c-mediated intrinsic apoptosis in tumor cells shows a high expression of this protein [4,5].